Natasja Brooijmans

Person

Boston, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
EGFR inhibitors
- Patent number 12,172,983
- Issue date Dec 24, 2024
- Blueprint Medicines Corporation
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2 inhibitors
- Patent number 11,970,498
- Issue date Apr 30, 2024
- Blueprint Medicines Corporation
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK2 inhibitors
- Patent number 11,932,648
- Issue date Mar 19, 2024
- Blueprint Medicines Corporation
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGFR inhibitors
- Patent number 11,718,602
- Issue date Aug 8, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 11,634,422
- Issue date Apr 25, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions useful for treating disorders related to...
- Patent number 11,046,697
- Issue date Jun 29, 2021
- Blueprint Medicines Corporation
- Steven Mark Wenglowsky
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,774,070
- Issue date Sep 15, 2020
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 10,233,186
- Issue date Mar 19, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors
- Patent number 10,202,365
- Issue date Feb 12, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions useful for treating disorders related to...
- Patent number 10,017,512
- Issue date Jul 10, 2018
- Blueprint Medicines Corporation
- Steven Mark Wenglowsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 9,340,514
- Issue date May 17, 2016
- Blueprint Medicines Corporation
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 9,126,951
- Issue date Sep 8, 2015
- Blueprint Medicines Corporation
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of the fibroblast growth factor receptor
- Patent number 8,802,697
- Issue date Aug 12, 2014
- Blueprint Medicines Corporation
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CDK2 INHIBITORS
- Publication number 20240383902
- Publication date Nov 21, 2024
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240299387
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS
- Publication number 20240287040
- Publication date Aug 29, 2024
- BLUEPRINT MEDICINES CORPORATION
- Philip D. Ramsden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20240158398
- Publication date May 16, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK2 INHIBITORS
- Publication number 20230322791
- Publication date Oct 12, 2023
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK2 INHIBITORS
- Publication number 20230159535
- Publication date May 25, 2023
- BLUEPRINT MEDICINES CORPORATION
- Douglas Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR INHIBITORS
- Publication number 20230056541
- Publication date Feb 23, 2023
- BLUEPRINT MEDICINES CORPORATION
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR INHIBITORS
- Publication number 20230026209
- Publication date Jan 26, 2023
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20220315585
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20190359591
- Publication date Nov 28, 2019
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20190359682
- Publication date Nov 28, 2019
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO...
- Publication number 20190169194
- Publication date Jun 6, 2019
- BLUEPRINT MEDICINES CORPORATION
- Steven Mark WENGLOWSKY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20180362613
- Publication date Dec 20, 2018
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS
- Publication number 20180022731
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20170298069
- Publication date Oct 19, 2017
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO...
- Publication number 20170066773
- Publication date Mar 9, 2017
- BLUEPRINT MEDICINES CORPORATION
- Steven Mark Wenglowsky
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20170066812
- Publication date Mar 9, 2017
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20150210694
- Publication date Jul 30, 2015
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20140378481
- Publication date Dec 25, 2014
- BLUEPRINT MEDICINES CORPORATION
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- Publication number 20140088100
- Publication date Mar 27, 2014
- BLUEPRINT MEDICINES
- Neil Bifulco
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Natasja Brooijmans

Person

Patents Grantslast 30 patents

EGFR inhibitors

CDK2 inhibitors

CDK2 inhibitors

EGFR inhibitors

Inhibitors of activin receptor-like kinase

Compounds and compositions useful for treating disorders related to...

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Inhibitors of activin receptor-like kinase

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Compounds and compositions useful for treating disorders related to...

Inhibitors of the fibroblast growth factor receptor

Inhibitors of the fibroblast growth factor receptor

Inhibitors of the fibroblast growth factor receptor

Patents Applicationslast 30 patents

CDK2 INHIBITORS

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

SUBSTITUTED PYRIMIDINYL-PYRAZOLES AS CDK2 INHIBITORS

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

CDK2 INHIBITORS

CDK2 INHIBITORS

EGFR INHIBITORS

EGFR INHIBITORS

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO...

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

2-(PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES AS RET INHIBITORS

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO...

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR

INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR